Fenoldopam Mesylate
甲磺酸非诺多泮
Report date: 2025/03/18 16:01:33
NME
Base Information
Drug NameFenoldopam Mesylate
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1997/09/23
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaDiscontinued
Originator CompaniesAbbott Laboratories
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesHospira IncUniversity Of VirginiaYangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications